Clinical Trial: Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Acute Ischemic Stroke
Study Type: INTERVENTIONAL
Official Title: Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke (CAPTAIN)--A Multicenter, Prospective, Randomized Trial
Brief Summary:
This study is an investigator-initiated, multicenter, prospective, open-label, endpoint-blinded, randomized controlled trial (PROBE design) that includes patients with moderate or severe symptomatic intracranial large vessel atherosclerotic stenosis (sICAS) who present with acute ischemic stroke within 48 hours of symptom onset.Patients will be centrally randomized in a 1:1 ratio into two groups:Experimental Group: A single subcutaneous injection of 420 mg evolocumab upon admission, combined with standard doses of…
Read more